Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy

Kidney International

Volumn 51, Issue 3, 1997, Pages 880-887

  Miyata, Toshio ^a   Ueda, Yasuhiko ^b   Yoshida, Atsuhiro ^b   Sugiyama, Satoshi ^b   Iida, Yoshiyasu ^b   Jadoul, Michel ^b   Maeda, Kenji ^b   Kurokawa, Kiyoshi ^b   Van Ypersele De Strihou, Charles ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PENTOSIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLEARANCE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; GLYCATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030934178     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.124     Document Type: Article

References (33)

1. BROWNLEE M, CERAMI A, VLASSARA H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
2. BAYNES JW, MONNIER VM: The Maillard reaction in aging, diabetes and nutrition. Prog Clin Biol Res 304:1-410, 1989
3. MAKITA Z, RADOFF S, RAYFIELD EJ, YANG Z, SKOLNIK E, DELANEY V, FRIEDMAN EA: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1990
4. MAKITA Z, BUCALA R, RAYFIELD EJ, FRIEDMAN EA, KAUFMAN AM, KORBET SM, BARTH RH, WINSTON JA, FUH H, MANOGUE KR, CERAMI A, VLASSARA H: Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 343:1519-1522, 1994
5. PAPANASTASIOU P, GRASS L, RODELA H, PATRIKAREA A, PREOPUOLOS D, DIAMANDIS EP: Immunological quantification of advanced glycosylation end products in the serum of patients on hemodialysis or CAPD. Kidney Int 46:216-222, 1994
6. KIRSTEIN M, BRETT J, RADOFF S, OGAWA S, STERN D, VLASSARA H: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014, 1990
7. VLASSARA H, BROWNLEE M, MANOGUE KR, DINARELLO CA, PASAGIAN A: Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science 240:1546-1548, 1988
8. MIYATA T, INAGI R, IIDA Y, SATO M, YAMADA N, ODA O, MAEDA M, SHO H: Involvement of β2-microglobulin modified with advanced glycation end products in the pathogencsis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1. J Clin Invest 93:521-528, 1994
9. IIDA Y, MIYATA T, INAGI R, SUGIYAMA S, MAEDA K: β2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: Role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem Biophys Res Commun 201: 1235-1241, 1994
10. MIYATA T, IIDA Y, UEDA Y, SHINZATO T, SEO H, MONNIER VM, MAEDA K, WADA Y: Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end products. Kidney Int 49:538-550, 1996
11. NEEPER M, SCHMIDT AM, BRETT J, YAN SD, WANG F, PAN YC, ELLISTON K, STERN D, SHAW A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004, 1992
12. SCHMIDT AM, YON SD, BRETT J, MORA R, NOWYGROD R, STERN D: Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 92:2155-2168, 1993
13. WAUTIER JL, WAUTIER MP, SCHMIDT AM, ANDERSON M, HORI O, ZOUKOURIAN C, CAPRON L, CHAPPEY O, YAN SD, BRETT J, GUILLAUSSEAU PJ, STERN D: Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 91:7742-7746, 1994
14. BAYNES JW: Perspectives in diabetes: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
15. SKOLNIK EY, YANG Z, MAKITA Z, RADOFF S, KIRSTEIN M, VLASSARA H: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931-939, 1991
16. DOI T, VLASSARA H, KIRSTEIN M, YAMADA Y, STRIKER GE, STRIKER LJ: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 89:2873-2877, 1992
17. MIYATA T, ODA O, INAGI R, IIDA Y, ARAKI N, YAMADA N, HORIUCHI S, TANIGUCHI N, MAEDA K, KINOSHITA T: β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92:1243-1252, 1993
18. MIYATA T, INAGI R, WADA Y, UEDA Y, IIDA Y, TAKAHASHI M, TANIGUCHI N, MAEDA K: Glycation of human β2-microglobulin in patients with hemodialysis-associated amyloidosis: Identification of the glycated sites. Biochemistry 33:12215-12221, 1994
19. MIYATA T, TANEDA S, KAWAI R, UEDA Y, HORIUCHI S, HARA M, MAEDA K, MONNIER VM: Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 93:2353-2358, 1996
20. SMITH MA, TANEDA S, RICHEY PL, MIYATA S, YAN SD, STERN D, SAYRE LM, MONNIER VM, PERRY G: Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91:5710-5714, 1994
21. YAN SD, YAN EF, CHEN X, JIN F, CHEN M, KUPPUSAMY P, SMITH MA, PERRY G, GODMAN GC, NAWROTH P, ZWEIER JL, STERN D: Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nature Med 1:693-699, 1995
22. SELL DR, MONNIER VM: Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 264:21597-21602, 1989
23. DYER DG, DUNN JA, THORPE SR, BAILIE KE, LYONS TJ, MCCANCE DR, BAYNES JW: Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91:2463-2469, 1993
24. BEISSWENGER PJ, MOORE LL, BRINK-JOHNSEN T: Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92:212-217, 1993
25. MONNIER VM, SELL DR, NAGARAJ RH, MIYATA S, GRANDHEE S, ODETTI P, IBRAHIM SA: Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 41:36-41, 1992
26. ODETTI P, FORGARTY J, SELL DR, MONNIER VM: Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41:153-159, 1992
27. TANEDA S, MONNIER VM: Enzyme-linked immunosorbent assay (ELISA) for pentosidine, an advanced glycation end product in biological specimens. Clin Chem 40:1766-1773, 1994
28. SELL DR, LAPOLLA A, ODETTI P, FORGARTY J, MONNIER VM: Pentosidine formation in skin correlates with seventy of complication in individuals with long standing IDDM. Diabetes 41:1286-1292, 1992
29. MCCANCE DR, DYER DG, DUNN JA, BAILIE KE, THROPE SR, BAYNES JW, LYONS TJ: Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91:2470-2478, 1993
30. FRIEDLANDER MA, WU YC, SCHULAK JA, MONNIER VM, HRICIK DE: Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. Am J Kidney Dis 25:445-451, 1995
31. MIYATA T, UEDA Y, SHINZATO T, IIDA Y, TANAKA S, KUROKAWA K, VAN YPERSELE DE STRIHOU C, MAEDA K: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7:1198-1206, 1996
32. FRIEDLANDER MA, WU YC, ELGAWISH A, MONNIER VM: Early and advanced glycosylation end products: Kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 97:728-735, 1996
33. HRICIK DE, SCHULAK JA, SELL DR, FOGARTY JF, MONNIER VM: Effects of kidney or kidney-pancreas transplantation on plasma pentosidine. Kidney Int 43:398-403, 1993